FDA Drug recall D-0140-2020
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manuf…
- FDA Drug
- Class II
- terminated
- Published 2019-10-23
On 2019-10-23 the FDA classified a Class II recall of Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manuf… by Macleods Pharma Usa, citing superpotent.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0140-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-09-23 |
| Published | 2019-10-23 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Macleods Pharma Usa |
| Distribution | n/a |
Product
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07
Reason
Superpotent
Identifiers
| ndc | 33342-054-07 |
|---|---|
| ndc | 33342-054-10 |
| ndc | 33342-054-15 |
| ndc | 33342-054-12 |
| ndc | 33342-055-07 |
| ndc | 33342-055-10 |
| ndc | 33342-055-15 |
| ndc | 33342-055-12 |
| ndc | 33342-056-07 |
| ndc | 33342-056-10 |
| ndc | 33342-056-15 |
| ndc | 33342-056-12 |
| code_info | Lot # BPF901A, exp. date 12/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0140-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.